ACTIVE MIND: An Adaptive Clinical Trial of Cognitive Training to Improve Function and Delay Dementia

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Older adults at risk for dementia show a variety of cognitive deficits, which can be ameliorated by different cognitive training (CT) exercises. The best combination of CT exercises is unknown. The aim is to discover the most efficacious combination of CT exercises as compared to cognitive stimulation (which will serve as a stringent, active control) to modify the functional trajectories of older adults' with MCI, who are at high risk for dementia. The primary objective of the U01 phase was to design and pilot-test an adaptive, randomized clinical trial (RCT) of cognitive training (CT) combinations aimed to enhance performance of instrumental activities of daily living (IADL) among persons with mild cognitive impairment (MCI). In the R01 phase, the objective is to identify the best combination of CT exercises to delay dementia onset among persons with MCI. The longitudinal endpoint goal is reducing incident dementia. The primary aim of the study is to determine which CT combination has the best probability to delay dementia by producing the largest IADL improvements. The study further aims to explore neuroimaging and novel blood-based biomarkers.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Maximum Age: 89
Healthy Volunteers: f
View:

• 55 to 89 years of age

• Montreal Cognitive Assessment Score of 18-27 inclusive

• History of some change in cognitive function relative to established baseline and either 1) a CDR of 0.5; or 2) CDR of 0 and a clinical diagnosis of mild cognitive impairment (MCI) based on a multidisciplinary evaluation that included standardized neuropsychological testing

• If reports use of medications typically prescribed for dementia such as Namenda, Memantine, Namzaric, Donepezil, Aricept, Rivastigmine, Exelon, Razadyne, Galantamine, or Reminyl, dose has been stable for at least 30 days

• Adequate auditory capacity to understand normal speech. No greater than moderate hearing loss evident by thresholds less than or equal to 50 dB at 1000 and 2000 Hz in at least one ear determined by an audioscope.

• Adequate visual capacity to read from a computer screen at a normal viewing distance as measured by binocular visual acuity of 20/50 or better tested with a standard near visual acuity chart

• Reports and shows adequate motor capacity to touch a computer screen or control a computer mouse.

• Wiling to complete all study activities

• Willing and capable of providing informed consent

• Ability to understand study procedures and comply with them for the length of the study

Locations
United States
California
University of California San Francisco
RECRUITING
San Francisco
Florida
University of Florida
RECRUITING
Gainesville
Minnesota
University of Minnesota
ACTIVE_NOT_RECRUITING
Minneapolis
South Carolina
Clemson University
RECRUITING
Seneca
Contact Information
Primary
Jerri Edwards, PhD
activemindcoordinator@gmail.com
864-916-6220
Backup
Jade Sutfin
activemindcoordinator@gmail.com
864-916-6220
Time Frame
Start Date: 2020-03-03
Estimated Completion Date: 2027-08-31
Participants
Target number of participants: 1305
Treatments
Experimental: CTa
Participants will complete computerized cognitive training. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Experimental: CTab
Participants will complete computerized cognitive training. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Experimental: CTac
Participants will complete computerized cognitive training. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Experimental: CTabc
Participants will complete computerized cognitive training. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Active_comparator: Computerized Cognitive Stimulation
Participants will complete cognitively-stimulating computer activities. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Authors
Jerri Edwards
Related Therapeutic Areas
Sponsors
Collaborators: University of Florida, National Institute on Aging (NIA), University of Minnesota, University of California, San Francisco, Clemson University
Leads: University of Alabama at Birmingham

This content was sourced from clinicaltrials.gov